Your browser doesn't support javascript.
loading
Activity of Estrogen Receptor ß Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer.
Datta, Jharna; Willingham, Natalie; Manouchehri, Jasmine M; Schnell, Patrick; Sheth, Mirisha; David, Joel J; Kassem, Mahmoud; Wilson, Tyler A; Radomska, Hanna S; Coss, Christopher C; Bennett, Chad E; Ganju, Ramesh K; Sardesai, Sagar D; Lustberg, Maryam; Ramaswamy, Bhuvaneswari; Stover, Daniel G; Cherian, Mathew A.
Afiliação
  • Datta J; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Willingham N; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Manouchehri JM; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Schnell P; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Sheth M; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, United States.
  • David JJ; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Kassem M; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Wilson TA; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Radomska HS; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, United States.
  • Coss CC; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Bennett CE; Medicinal Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Ganju RK; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, United States.
  • Sardesai SD; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Lustberg M; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, United States.
  • Ramaswamy B; Drug Development Institute, The Ohio State University, Columbus, OH, United States.
  • Stover DG; Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
  • Cherian MA; Medicinal Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Front Oncol ; 12: 857590, 2022.
Article em En | MEDLINE | ID: mdl-35574319

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos